Medicine

This page is only for payment of accepted students only. Please do not use unless you have recieved an invite from the Professional Education Office to do so. 

Why join this course?

Botulinum toxin type A (Botox, Dysport, Xeomin) blocks the release of a neurotransmitter known as acetylcholine from nerve cells. Acetylcholine normally transmits nerve impulses to muscle cells, causing them to contract. Without acetylcholine, the affected nerve is unable to send a signal to the muscle it supplies, resulting in a weakened or paralysed muscle. The effect of Botox injections is restricted to the area being treated.

The aim of the injection therapy module is to enable practitioners from relevant health care professions to develop in-depth knowledge and understanding of how the mechanisms of Botulinum Toxin action are related to therapeutic and adverse effects. This will allow for practitioners to advance their practice as independent injectors developing roles such as ACPs and enable autonomous practice.  Medical practitioners will develop greater skills around injection therapy including localisation techniques, and case study analysis to enable advanced clinical reasoning skills  

Audience

This credit bearing module is particularly suited to: physiotherapists, consultant stroke physicians, Rehabilitation medicine and neurology trainees, and nurses.